Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256)

Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) is a fully humanized IgG2κ monoclonal antibody that targets the B-cell growth factor APRIL (TNFSF13), with the potential to treat IgA nephropathy (IgAN). MW : 145.5 KD.
Supplier Selleck Chemicals
Product # A2317
Sku # A2317-1mg*5
Pricing 1mg*5, $790.00
Feedback